NanJing Pharmaceutical Co Ltd (600713)

Shanghai
Currency in CNY
5.24
0.00(0.00%)
Closed·
600713 Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
600713 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.205.25
52 wk Range
4.065.64
Key Statistics
Edit
Bid/Ask
5.23 / 5.24
Prev. Close
5.24
Open
5.24
Day's Range
5.2-5.25
52 wk Range
4.06-5.64
Volume
11.33M
Average Volume (3m)
10.53M
1-Year Change
21.02%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600713 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

NanJing Pharmaceutical Co Ltd Company Profile

NanJing Pharmaceutical Company Limited engages in the pharmaceutical wholesale and retail businesses in China. It also operates an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Employees
4830
Market
China

Compare 600713 to Peers and Sector

Metrics to compare
600713
Peers
Sector
Relationship
P/E Ratio
12.0x11.9x−0.5x
PEG Ratio
−7.64−0.070.00
Price/Book
1.0x1.3x2.6x
Price / LTM Sales
0.1x0.8x3.2x
Upside (Analyst Target)
-20.5%45.4%
Fair Value Upside
Unlock27.7%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.44%
Dividend Yield
3.24%
Industry Median 1.57%
Annualised payout
0.17
Paid annually
5-Years Growth
+11.20%
Growth Streak

Earnings

Latest Release
Apr 10, 2025
EPS / Forecast
0.10 / --
Revenue / Forecast
12.76B / --
EPS Revisions
Last 90 days

600713 Income Statement

FAQ

What Stock Exchange Does NanJing Pharm Trade On?

NanJing Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for NanJing Pharm?

The stock symbol for NanJing Pharm is "600713."

What Is the NanJing Pharm Market Cap?

As of today, NanJing Pharm market cap is 6.86B.

What Is NanJing Pharm's Earnings Per Share (TTM)?

The NanJing Pharm EPS (TTM) is 0.44.

From a Technical Analysis Perspective, Is 600713 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has NanJing Pharm Stock Split?

NanJing Pharm has split 4 times.

How Many Employees Does NanJing Pharm Have?

NanJing Pharm has 4830 employees.

What is the current trading status of NanJing Pharm (600713)?

As of 13 Jul 2025, NanJing Pharm (600713) is trading at a price of 5.24, with a previous close of 5.24. The stock has fluctuated within a day range of 5.20 to 5.25, while its 52-week range spans from 4.06 to 5.64.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.